(VIANEWS) – Amphastar Pharmaceuticals (AMPH), Oceaneering International (OII), Brown & Brown (BRO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Amphastar Pharmaceuticals (AMPH)
34% sales growth and 24.59% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.56.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 23.8. Meaning, the purchaser of the share is investing $23.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.59%.
Previous days news about Amphastar Pharmaceuticals(AMPH)
- According to Zacks on Friday, 29 December, "While Amphastar Pharmaceuticals currently sports a Zacks Rank #1 (Strong Buy), Elevance Health and Penumbra carry a Zacks Rank #2 (Buy), at present. ", "Shares of Amphastar Pharmaceuticals and Elevance Health have gained 8.2% and 5.5%, respectively, in the past six months. "
2. Oceaneering International (OII)
19.4% sales growth and 14.48% return on equity
Oceaneering International, Inc. provides engineered services and products, and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries worldwide. The company's Subsea Robotics segment provides remotely operated vehicles (ROVs) for drill support and vessel-based services, including subsea hardware installation, construction, pipeline inspection, survey and facilities inspection, maintenance, and repair. This segment also offers ROV tooling, and survey services, such as hydrographic survey and positioning services, as well as autonomous underwater vehicles for geoscience. Its Manufactured Products segment provides distribution and connection systems, including production control umbilicals and field development hardware, pipeline connection, and repair systems to the energy industry; and autonomous mobile robots technology and entertainment systems to various industries. The company's Offshore Projects Group segment offers subsea installation and intervention, including riserless light well intervention services and inspection, and maintenance and repair services; installation and workover control systems, and ROV workover control systems; diving services; project management and engineering; and drill pipe riser services and systems, and wellhead load relief solutions. Its Integrity Management & Digital Solutions segment provides asset integrity management; software and analytical solutions for the bulk cargo maritime industry; and software, digital, and connectivity solutions for the energy industry. The company's Aerospace and Defense Technologies segment offers government services and products, including engineering and related manufacturing in defense and space exploration activities to U.S. government agencies and their prime contractors. Oceaneering International, Inc. was founded in 1964 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Oceaneering International has a trailing twelve months EPS of $0.75.
PE Ratio
Oceaneering International has a trailing twelve months price to earnings ratio of 28.96. Meaning, the purchaser of the share is investing $28.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.48%.
Yearly Top and Bottom Value
Oceaneering International’s stock is valued at $21.72 at 19:22 EST, way below its 52-week high of $27.46 and way above its 52-week low of $14.99.
Moving Average
Oceaneering International’s value is under its 50-day moving average of $21.85 and above its 200-day moving average of $20.45.
Volume
Today’s last reported volume for Oceaneering International is 797646 which is 19.25% below its average volume of 987801.
Previous days news about Oceaneering International(OII)
- Oceaneering international (oii) dips more than broader market: what you should know. According to Zacks on Friday, 29 December, "The investment community will be closely monitoring the performance of Oceaneering International in its forthcoming earnings report. ", "From a valuation perspective, Oceaneering International is currently exchanging hands at a Forward P/E ratio of 25.14. "
3. Brown & Brown (BRO)
14.7% sales growth and 15.71% return on equity
Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, Cayman Islands, Ireland, and the United Kingdom. It operates through four segments: Retail, National Programs, Wholesale Brokerage, and Services. The company offers builders risk, group medical and pharmaceutical, property, commercial auto, homeowners, reinsurance, crop and hail, inland marine, retirement benefit, cyber, disability, risk mitigating warranty products, directors and officers, management liability, errors and omissions, medical stop loss, term life, excess liability, personal auto, umbrella, general liability, prescription drug, workers compensation, and group dental insurance products. It also provides professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, and real estate title professionals, as well as supplementary insurance-related products for weddings, events, medical facilities, and cyber liability; homeowners and personal property policies, residential earthquake, and private passenger automobile and motorcycle coverage; commercial and public entity-related programs; and flood insurance, commercial difference-in-conditions, all-risk commercial property, coastal property programs, lender-placed solutions, sovereign Indian nations, and parcel insurance. In addition, it provides markets and sells excess and surplus commercial insurance products, such as personal lines, homeowners, yachts, jewelry, commercial property and casualty, commercial automobile, garage, restaurant, builder's risk, and inland marine lines; and third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, as well as Medicare Set-aside, Social Security disability, Medicare benefits advocacy, and claims adjusting services. The company was founded in 1939 and is headquartered in Daytona Beach, Florida.
Earnings Per Share
As for profitability, Brown & Brown has a trailing twelve months EPS of $2.63.
PE Ratio
Brown & Brown has a trailing twelve months price to earnings ratio of 27.01. Meaning, the purchaser of the share is investing $27.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.71%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 6% and 13.1%, respectively.
Moving Average
Brown & Brown’s worth is under its 50-day moving average of $71.75 and above its 200-day moving average of $67.35.
4. CVS Health (CVS)
8.9% sales growth and 11.67% return on equity
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $6.53.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 12.07. Meaning, the purchaser of the share is investing $12.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.67%.
Previous days news about CVS Health(CVS)
- CVS health (cvs) stock moves -0.01%: what you should know. According to Zacks on Friday, 29 December, "Its industry sports an average Forward P/E of 7.97, so one might conclude that CVS Health is trading at a premium comparatively.", "The investment community will be paying close attention to the earnings performance of CVS Health in its upcoming release. "
5. Westinghouse Air Brake Technologies Corporation (WAB)
8.7% sales growth and 7.56% return on equity
Westinghouse Air Brake Technologies Corporation provides technology-based locomotives, equipment, systems, and services for the freight rail and passenger transit industries worldwide. The company operates in two segments, Freight and Transit. The Freight segment manufactures and services components for freight cars and locomotives; builds, rebuilds, upgrades, and overhauls locomotives; supplies railway electronics, positive train control equipment, and signal design and engineering services; services locomotives and freight cars; and provides heat exchange and cooling systems, and components and digital solutions. It serves publicly traded railroads; leasing companies; manufacturers of original equipment; and utilities. The Transit segment offers components for new and existing passenger transit vehicles, such as regional and high speed trains, subway cars, light-rail vehicles, and buses; refurbishes subway cars; and provides heating, ventilation, and air conditioning equipment, as well as doors for buses and subways. This segment serves public transit authorities and municipalities, leasing companies, and manufacturers of subway cars and buses. The company also provides electronically controlled pneumatic braking products; freight car trucks; draft gears, couplers, and slack adjusters; air compressors and dryers; track and switch products; railway and freight braking equipment and related components; friction products; access and platform screen doors; pantographs; energy measuring systems; auxiliary power converter and battery charging products; antifire systems; passenger information systems and CCTV; signaling and railway electric relays; sanitation systems; window assemblies; accessibility lifts and ramps for buses; and electric charging solutions for buses and electric ferries. In addition, it offers freight locomotive overhaul, modernizations, and refurbishment services. The company was founded in 1869 and is headquartered in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Westinghouse Air Brake Technologies Corporation has a trailing twelve months EPS of $4.2.
PE Ratio
Westinghouse Air Brake Technologies Corporation has a trailing twelve months price to earnings ratio of 30.15. Meaning, the purchaser of the share is investing $30.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.56%.
Volume
Today’s last reported volume for Westinghouse Air Brake Technologies Corporation is 588221 which is 36.1% below its average volume of 920545.
